title: Rebuttal of the Pro View: Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD.
authors.affiliation: Veterans Affairs Pittsburgh Healthcare System, University of Pittsburgh, Pittsburgh, Pennsylvania; and Linda.Fried@va.gov.
authors.forename: Linda F
authors.initials: LF
authors.lastname: Fried
authors.affiliation: Vanderbilt University School of Medicine, Nashville, Tennessee.
authors.forename: Julia
authors.initials: J
authors.lastname: Lewis
mesh_terms: D000419:Albuminuria / Q000628:therapy*; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D051436:Renal Insufficiency, Chronic / Q000628:therapy*; D012709:Serum Albumin / Q000378:metabolism*; D064804:Urological Agents / Q000627:therapeutic use*
chemical_list: D012709:Serum Albumin; D064804:Urological Agents
keywords: CKD; albuminuria; biomarker; end point; risk factors; surrogate